Gene · 59341
Papers4,540
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 4,540
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Low hydrostatic pressure promotes functional homeostasis of nucleus pulposus cells through the TRPV4/CRT/FA complex axis. | Front Med (Lausanne) | 2025 | 39944489 | PubTator, text mining | PubMed |
| Discovery of TRPV4-Targeting Small Molecules with Anti-Influenza Effects Through Machine Learning and Experimental Validation. | Int J Mol Sci | 2025 | 39941149 | PubTator, text mining | PubMed |
| Ex Vivo and In Vitro Proteomic Approach to Elucidate the Relevance of IL-4 and IL-10 in Intervertebral Disc Pathophysiology. | JOR Spine | 2025 | 39931581 | PubTator, text mining | PubMed |
| Expression of Concern: "Shexiang Baoxin Pill treats acute myocardial infarction by promoting angiogenesis via GDF15-TRPV4 signaling" [Biomed. Pharmacother. 165 (2023) 115186]. | Biomed Pharmacother | 2025 | 39914990 | PubTator, text mining | PubMed |
| Phosphorylation of distal C-terminal residues promotes TRPV4 channel activation in response to arachidonic acid. | J Biol Chem | 2025 | 39909371 | PubTator, text mining | PubMed |
| Targeting gut S. aureofaciens Tü117 serves as a new potential therapeutic intervention for the prevention and treatment of hypertension. | Cell Metab | 2025 | 39908987 | PubTator, text mining | PubMed |
| The in vitro and in vivo skin-whitening activity of Ectoine through enhanced autophagy in melanocytes and keratinocytes and zebrafish model. | Biofactors | 2025 | 39907116 | PubTator, text mining | PubMed |
| Matrix stiffness regulates NPC invasiveness by modulating a mechanoresponsive TRPV4-Nox4-IL-8 signaling axis. | J Cancer | 2025 | 39895789 | PubTator, text mining | PubMed |
| Hip Dysplasia in Charcot-Marie-Tooth Disease: Insights From a Large Cohort of Children and Adolescents. | J Peripher Nerv Syst | 2025 | 39887493 | PubTator, text mining | PubMed |
| Chewing-Activated TRPV4/PIEZO1-HIF-1α-Zn Axes in a Rat Periodontal Complex. | J Dent Res | 2025 | 39876056 | PubTator, text mining | PubMed |
| Tuning local matrix compliance accelerates mesenchymal stem cell chondrogenesis in 3D sliding hydrogels. | Biomaterials | 2025 | 39827509 | PubTator, text mining | PubMed |
| TRPV4 as a Novel Regulator of Ferroptosis in Colon Adenocarcinoma: Implications for Prognosis and Therapeutic Targeting. | Dig Dis Sci | 2025 | 39826064 | PubTator, text mining | PubMed |
| Comparison of the natural course of clinical and radiologic features in 13 patients with TRPV4-related skeletal dysplasias. | Pediatr Radiol | 2025 | 39825918 | PubTator, text mining | PubMed |
| Stay connected: The myoendothelial junction proteins in vascular function and dysfunction. | Vascul Pharmacol | 2025 | 39814089 | PubTator, text mining | PubMed |
| Synergistic effects of NO/H2S gases on antibacterial, anti-inflammatory, and analgesic properties in oral ulcers using a gas-releasing nanoplatform. | Acta Biomater | 2025 | 39798637 | PubTator, text mining | PubMed |
| The Influence of Phosphoinositide Lipids in the Molecular Biology of Membrane Proteins: Recent Insights from Simulations. | J Mol Biol | 2025 | 39793883 | PubTator, text mining | PubMed |
| Polyunsaturated fatty acids suppress PIEZO ion channel mechanotransduction in articular chondrocytes. | FASEB J | 2025 | 39786170 | PubTator, text mining | PubMed |
| Corrigendum to "Modulating TRPV4 channels with paclitaxel and lithium" [Cell Calcium 91 (2020) 102266]. | Cell Calcium | 2025 | 39746287 | PubTator, text mining | PubMed |
| Investigating the Role of TRPV4 and GPR35 Interaction in Endothelial Dysfunction in Aging Mice. | Aging Cell | 2025 | 39744893 | PubTator, text mining | PubMed |
| Transient Receptor Potential Vanilloid 4 Calcium-Permeable Channel Contributes to Valve Stiffening in Aortic Stenosis. | J Am Heart Assoc | 2025 | 39719407 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/59341/papers?page=17